Impact and Utility of PET Versus Clinical Score for the Assessment of Inflammatory Activity in Takayasu Arteritis

Learn more about:
Related Clinical Trial
A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK) Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu Arteritis A Pilot Study in Severe Patients With Takayasu Arteritis. Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients Drug-coated Balloon for Takayasu Arteritis Associated Renal Artery Stenosis The Registry Study of Takayasu Arteritis in East China Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases A Registry Study on Biomarkers of Takayasu’s Arteritis (ARSBTA) Infliximab Biosimilar in Takayasu’s Arteritis Exercise in Juvenile Takayasu Disease Pulmonary Artery Involvement in Takayasu’s Arteritis Anti-inflammatory Treatment for Inactive Takayasu Arteritis Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis Aerobic Capacity and Strength Exercise in Takayasu’s Arteritis Use of MRI and PET for Assessing Disease Activity in Takayasu’s Arteritis Impact and Utility of PET Versus Clinical Score for the Assessment of Inflammatory Activity in Takayasu Arteritis Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu’s Arteritis Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis Registration Study of Takayasu’s Arteritis in China Determining Disease Activity Biomarkers in Individuals With Takayasu’s Arteritis Takayasu Arteritis Activity Evaluation by Ultrafast Ultrasound Imaging China Takayasu Arteritis Registry (CTA Registry) Takayasu Arteritis Clinical Trial in China

Brief Title

Impact and Utility of PET Versus Clinical Score for the Assessment of Inflammatory Activity in Takayasu Arteritis

Official Title

Impact and Utility of Positron Emission Tomography (PET) for the Assessment of Inflammatory Activity Arteritis Versus Clinical Score and Laboratory Values in Takayasu Arteritis: a Cohort Study

Brief Summary

      The purpose of this study is to demonstrate that [18F]FDG PET is a a better method than
      clinical and laboratory values for the identification and assessment of inflammatory activity
      in patients with Takayasu Arteritis (TA), allowing long-term follow-up with a precise
      evaluation of response to therapy.
    

Detailed Description

      Inflammatory activity and fibrosis are the main causes of morbidity and mortality in patients
      with Takayasu arteritis. The investigators objective is to determine the utility of using
      18F-FDG PET in the basal evaluation and follow-up of patients and compare the results with
      Dabague's clinical score.
    


Study Type

Observational




Condition

Takayasu Arteritis



Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information



Estimated Enrollment

26

Start Date

February 2010

Completion Date

February 2011

Primary Completion Date

February 2011

Eligibility Criteria

        Inclusion Criteria:

          -  TA was diagnosed if the patient met 3 or more ACR criteria.
      

Gender

All

Ages

N/A - N/A

Accepts Healthy Volunteers

No

Contacts

Maria E Soto, MD, , 

Location Countries

Mexico

Location Countries

Mexico

Administrative Informations


NCT ID

NCT01532167

Organization ID

12-755


Responsible Party

Principal Investigator

Study Sponsor

Instituto Nacional de Cardiologia Ignacio Chavez


Study Sponsor

Maria E Soto, MD, Principal Investigator, Instituto Nacional de Cardiologia


Verification Date

March 2012